UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016026
Receipt number R000018633
Scientific Title Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc.
Date of disclosure of the study information 2015/01/15
Last modified on 2018/07/06 11:55:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc.

Acronym

Development of iPS cell stock from bone marrow transplant donors

Scientific Title

Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc.

Scientific Title:Acronym

Development of iPS cell stock from bone marrow transplant donors

Region

Japan


Condition

Condition

healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

The purpose of this study is the development of induced pluripotent stem (iPS) cell stock to be used for regenerative medicine. Donors of the derivatization of iPS cells are healthy HLA homozygous donors, whose HLA haplotypes are frequently found in Japanese population and who have registerd to Japan Bone Marrow Bank and have donated bone marrow etc. After informed concents from donors within inclusion criteria and tissue sourcing, human transplantable-grade iPS cells will be derived and stocked. For human transplantation, another research protocol will be submitted.

Basic objectives2

Others

Basic objectives -Others

Development of novel technologies towards clinical application by human stem cells

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Charactrization of iPS cells derived from HLA homozyougous donor.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Voluntary, non-remunerated, healthy donors who have donated bone marrow etc.
2)Individuals capable of giving voluntary, informed consent in writing

Key exclusion criteria

1)Enrolling related studies of generating iPSC banks
2)The following viral infection:
Hepatic Virus B
Hepatic Virus C
Human Immunodeficiency Virus
Human T-cell leukemia virus
Human parvovirus B19
Cytomegalovirus
3)The following microbial infection:
Treponema pallidum
West Nile Virus
Chlamydiaceae
Genus Neisseria
Mycobacterium
Malaria parasites(Plasmodium spp.)
Babesia
Trypanosoma cruzi
Leishmania
Trypanosoma brucei
4)Malignant neoplasm
5)Transmissible spongiform encephalopathy (including suspected case), Dementia or cognitive impairment, Stroke, Seizure
6)The following conditions:
Particular or genetic/hereditary disorders
Severe or uncontrolled metabolic or endocrinal disorders
Connective tissue diseases
Severe or uncontrolled hematologic diseases
Severe or uncontrolled hepatic disorders

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name ShinyaYamanaka

Organization

Center for iPS Cell Research and Application (CiRA), Kyoto University

Division name

Department of Reprogramming Science

Zip code


Address

53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

TEL

075-366-7000

Email

yamanaka@cira.kyoto-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name AyumiMatsunaga

Organization

Center for iPS Cell Research and Application (CiRA), Kyoto University

Division name

Medical Application Promotion Office

Zip code


Address

53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan

TEL

075-366-7008

Homepage URL


Email

ips-promotion@cira.kyoto-u.ac.jp


Sponsor or person

Institute

Center for iPS Cell Research and Application (CiRA), Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 12 Month 09 Day

Date of IRB


Anticipated trial start date

2015 Year 02 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Charactrization of iPS cells derived from HLA homozyougous donor.


Management information

Registered date

2014 Year 12 Month 22 Day

Last modified on

2018 Year 07 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018633


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name